A nasal hemostasis device

Abstract

The present invention provides a nasal hemostasis device, which belongs to the technical field of medical devices, and comprises a supporting body and a hemostasis airbag. The gas passage of the supporting body comprises a first gas passage and a second gas passage. The first gas passage inflates the front airbag of the hemostasis airbag to make it expand, and the second gas passage inflates the rear airbag of the hemostasis airbag to make it expand. A steering part and a connecting bag are provided between the front airbag and the rear airbag. The steering part bends the device to form an angle suitable for the human nasal cavity, and the connecting bag is used for hemostasis at the gap position between the front airbag and the rear airbag. The device has the technical effect of quickly judging the position of the nasal bleeding point and timely and effectively controlling the nasal bleeding.

Description

Technical Field

[0001] The invention relates to a nasal hemostasis device, which is used for hemostasis after nasal blood vessel bleeding and belongs to the technical field of medical devices. Background Art

[0002] Nosebleed is one of the common diseases in outpatient clinics. It is more common in spring and autumn. In mild cases, there is only blood in the mucus, while in severe cases, it can cause hemorrhagic shock. The site of the disease can be anywhere in the nasal cavity. In adolescents and children, it is mostly the bleeding area in the front of the nasal cavity, namely the Li area, while in middle-aged and elderly people, it is mainly concentrated in the back of the nasal cavity, mostly the nasal-nasopharyngeal venous plexus. The focus of nosebleed diagnosis is to find out the cause and the location of the bleeding point. The cause of nosebleed is more complicated and can be roughly divided into two categories, namely local factors and systemic factors. Local factors include: trauma, tumors of the nasal cavity, paranasal sinuses, and nasopharynx, foreign bodies in the nasal cavity, barotraumatic sinusitis, etc.; systemic factors include: acute febrile infectious diseases, heart and circulatory system diseases, hemorrhagic diseases, liver and kidney diseases, and rheumatic fever, etc. Different causes of nosebleeds can lead to different locations of bleeding points and different amounts of bleeding. For example, severe head and facial trauma that injures the maxillary artery, anterior and posterior ethmoid arteries, and sphenopalatine artery will cause heavy and severe bleeding, often leading to fatal nosebleeds. Arterial bleeding caused by hypertension, arteriosclerosis, hypertensive nephritis, eclampsia and other diseases often results in bleeding in the middle and posterior segments of the nasal cavity or the top of the nasal cavity. The bleeding is bright red, fluctuating, and can stop suddenly. Clinically, when a patient suddenly has a large amount of nose bleeding, there is often no time to analyze the cause, and the only treatment is symptomatic treatment to stop the bleeding first to avoid serious consequences caused by large amounts of bleeding.

[0003] In the prior art, medical staff first use an anterior rhinoscope to observe whether there are bleeding points in the nasal cavity and the front of the nasal septum. If the anterior rhinoscope cannot find the bleeding point, they use a nasal endoscope to find the bleeding point in the back of the nasal cavity, enter the nasopharynx and the posterior nasal cavity through the middle nasal meatus, observe the source of blood flow, find the specific location of the bleeding point, and finally use vaseline gauze or hemostatic balloon packing. However, in reality, finding the bleeding point is very difficult and time-consuming. If the patient continues to bleed heavily during the search time, it is likely to cause hemorrhagic shock to the patient and serious panic to the patient's family members.

[0004] Therefore, researchers in this field are in urgent need of developing a nasal hemostasis device that can quickly determine the location of nasal bleeding points, promptly and effectively control nasal bleeding, and allow patients to wear a comfortable nasal hemostasis device during treatment. Summary of the invention

[0005] The technical problem to be solved by the present invention is how to provide a nasal hemostasis device which can quickly determine the location of nasal bleeding points, timely and effectively control nasal bleeding, and conform to the internal angle of the patient's nasal cavity.

[0006] The present invention provides a nasal hemostasis device, comprising: a supporting body and a hemostatic airbag, wherein the supporting body is provided with a gas passage required for gas to expand the hemostatic airbag, the gas passage at least comprising a first gas passage and a second gas passage, the hemostatic airbag at least comprising a front airbag and a rear airbag, the rear airbag being located at the lower part of the front airbag, and being attached to the outer surface of the supporting body when not inflated, the first gas passage is used to inflate the front airbag to expand it, and a cavity formed after the expansion is the front airbag cavity, the second gas passage is used to inflate the rear airbag to expand it, and a cavity formed after the expansion is the rear airbag cavity, a steering part is provided on the supporting body between the front airbag and the rear airbag, the steering part can be bent, so that the supporting body between the front airbag and the rear airbag is bent, and the bending angle is conformable to the human nasal cavity; a connecting bag is provided between the front airbag and the rear airbag, one end of the connecting bag is fixed on the front airbag, and the other end is fixed on the rear airbag, and the whole covers the steering part, and the cavity formed by the connecting bag is the connecting cavity.

[0007] Preferably, the gas passage is located inside the support body, and the gas passage includes a first gas passage and a second gas passage. The hemostatic airbag includes a front airbag and a rear airbag, and the front airbag is adjacent to the top of the support body.

[0008] Preferably, the support body is in the shape of an elongated tube, and the hollow inner cavity formed by the tube wall is a nasal ventilation cavity. A gas passage is provided inside the tube wall, one end of the gas passage is connected to the hemostatic air bag, and the other end extends to the end of the support body to be connected to an external air source.

[0009] Preferably, the gas passage further comprises a third gas passage, and the third gas passage is used to inflate the connecting bag to make it expand.

[0010] Preferably, the steering part is a bellows, which is a part of the supporting body. A front airbag is provided at the upper end and a rear airbag is provided at the lower end. When the bellows is bent, a part is squeezed and shortened, and the opposite side is stretched and lengthened, so that the supporting body bends to form an angle suitable for the human nasal cavity.

[0011] Preferably, the steering portion is a metal component pre-set inside the tube wall of the supporting body. When the metal component is bent, the supporting body is bent to form an angle suitable for the human nasal cavity.

[0012] Preferably, the steering part is a metal shaping hose, which is a part of the supporting body, with a front airbag at the upper end and a rear airbag at the lower end. When the metal shaping hose is bent, the supporting body bends to form an angle suitable for the human nasal cavity.

[0013] Preferably, the gas passage of the supporting body is connected to a gas control valve, one end of which is connected to an external gas source, and the other end of which is connected to the first gas passage and the second gas passage, indicating and controlling the external gas source to inflate the first gas passage or the second gas passage. The external gas source is a manual inflatable bag or an electric air pump.

[0014] Preferably, a pressure relief port is provided on the gas passage of the support body, and a pressure relief valve is provided on the outer surface of the support body. The pressure relief valve seals the pressure relief port. When the pressure in the hemostatic airbag exceeds the safe pressure relief threshold, the pressure relief valve releases the seal of the pressure relief port to relieve pressure.

[0015] Preferably, a cryogenic liquid bag is further provided inside the front airbag and the rear airbag, and the cryogenic liquid is filled into the cryogenic liquid bag through the liquid bag pipeline. After the cryogenic liquid bag is filled and expanded, the outer surface of the cryogenic liquid bag is respectively in contact with the inner surface of the front airbag and the inner surface of the rear airbag.

[0016] Preferably, the device further comprises a pressure monitoring component, wherein the pressure monitoring component is used to monitor the cavity pressure of the front airbag cavity and / or the rear airbag cavity.

[0017] Preferably, pits are provided on the outer surfaces of the front airbag, the rear airbag and the connecting bag, and thrombin is provided inside the pits.

[0018] Preferably, the outer surface of the supporting body is provided with a size mark, and the size mark indicates the depth of the device entering the nasal cavity, which assists in determining the location of the bleeding point.

[0019] The nasal hemostasis device provided by the present invention has the following technical effects:

[0020] First, by inflating the front and rear air bags separately, the hemostasis situation can be observed, the location of the nasal bleeding point can be assisted in determining, and nasal bleeding can be accurately and effectively controlled. This not only avoids the pressure of the air bags on the nasal mucosa in the non-bleeding position, but also facilitates the doctor's accurate treatment of the bleeding point in the later stage.

[0021] Secondly, the present invention adopts a method of supporting the main body to turn so that the device can be conformed to the human nasal cavity, reducing the pain of the patient during the hemostasis process.

[0022] Third, the use of low-temperature liquid sacs can enhance the hemostatic effect and have the technical effect of relieving the patient's pain. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 It is a schematic cross-sectional view of the structure of the first embodiment of the nasal hemostasis device of the present invention;

[0024] Figure 2 It is a schematic diagram of the enlarged structure of part A of the first embodiment of the nasal hemostasis device of the present invention;

[0025] Figure 3It is a schematic diagram of the enlarged structure of part B of the first embodiment of the nasal hemostasis device of the present invention;

[0026] Figure 4 It is a schematic diagram of the enlarged structure of part C of the first embodiment of the nasal hemostasis device of the present invention;

[0027] Figure 5 It is a schematic diagram of the cross-section structure of the steering part in the first embodiment of the nasal hemostasis device of the present invention;

[0028] Figure 6 It is a schematic diagram of the three-dimensional structure of the first embodiment of the nasal hemostasis device of the present invention;

[0029] Figure 7 It is a schematic diagram of the cross-sectional structure of the gas control valve in the first embodiment of the nasal hemostasis device of the present invention;

[0030] Figure 8 It is a schematic cross-sectional view of the second embodiment of the nasal hemostasis device of the present invention;

[0031] Fig. 9 It is a schematic diagram of the cross-section structure of the turning part of the second embodiment of the nasal hemostasis device of the present invention;

[0032] Fig.10 It is a schematic cross-sectional view of the structure of the third embodiment of the nasal hemostasis device of the present invention;

[0033] Fig.11 It is a schematic diagram of the cross-section structure of the turning part of the third embodiment of the nasal hemostasis device of the present invention;

[0034] Description of reference numerals:

[0035] 1. Support the main body;

[0036] 10. Nasal ventilation cavity;

[0037] 11. Gas passage;

[0038] 111. First gas passage;

[0039] 111a. The first gas path inlet;

[0040] 111b. The first gas path outlet;

[0041] 112. Second gas passage;

[0042] 112a. Second gas path inlet;

[0043] 112b. The second gas outlet;

[0044] 113. The third gas passage;

[0045] 113a. The third gas line inlet;

[0046] 113b. The third gas outlet;

[0047] 114. Pressure relief port;

[0048] 12. Steering part;

[0049] 121. Bellows;

[0050] 122. Metal parts;

[0051] 123. Metal shaped hose;

[0052] 13. Tube wall;

[0053] 2. Hemostatic airbag;

[0054] 21.Front airbag;

[0055] 210. Front airbag cavity;

[0056] 22. Rear airbag;

[0057] 220. Rear airbag cavity;

[0058] 23. Connecting capsule;

[0059] 230. Connecting cavity;

[0060] 3. Size marking;

[0061] 5. Gas control valve;

[0062] 51. Pointer;

[0063] 52. Logo;

[0064] 53. Upper board;

[0065] 54. Lower board;

[0066] 55. Block valve;

[0067] 56. Connecting pipe;

[0068] 6. External air source;

[0069] 60. Inflatable sac cavity;

[0070] 61. Inflatable bag;

[0071] 62. Air pump;

[0072] 63. One-way valve;

[0073] 71. Pressure relief valve;

[0074] 72. Cryogenic sac;

[0075] 73. Hemostatic gel;

[0076] 74. Pressure monitoring components;

[0077] 75. Pit. DETAILED DESCRIPTION

[0078] Exemplary embodiments will be described in detail herein, examples of which are shown in the accompanying drawings. When the following description refers to the drawings, the same numbers in different drawings represent the same or similar elements unless otherwise indicated. The implementations described in the following exemplary embodiments do not represent all implementations consistent with the present disclosure. Instead, they are merely examples of devices and methods consistent with some aspects of the present disclosure as detailed in the claims.

[0079] The present invention provides a nasal hemostasis device, which is used for hemostasis of nasal bleeding points and determination of bleeding locations. The first embodiment of the nasal hemostasis device provided by the present invention is introduced below.

[0080] like Figure 1 As shown, in the first embodiment of the nasal hemostasis device provided by the present invention, the nasal hemostasis device includes a support body 1 and a hemostatic airbag 2. The support body 1 is slender and made of medical-grade flexible material. One end of the hemostatic airbag 2 provided on the support body 1 is arranged inside the human nasal cavity, and the other end is arranged outside the human nasal cavity. The support body 1 is formed by enclosing a tube wall 13. The inner hollow of the tube wall 13 is a nasal ventilation cavity 10. When the nasal cavity is in a hemostatic state, the nasal ventilation cavity 10 is used to ventilate the human nose or discharge nasal coagulation. The hemostatic airbag 2 is slender and made of conformable medical silicone material or rubber material. Before the hemostatic airbag 2 is not inflated, it is attached to one end of the support body 1 placed in the nasal cavity.

[0081] like Figures 2 to 4As shown, in order to accurately find the location of the nasal bleeding point and stop bleeding quickly, the hemostatic airbag 2 is divided into a front airbag 21 and a rear airbag 22. A gas passage 11 is buried inside the tube wall 13. The gas passage 11 includes a first gas passage 111 and a second gas passage 112. The two ends of the front airbag 21 are fixed to the outer surface of the supporting body 1. When not inflated, it is attached to the outer surface of the supporting body 1. The external air source 6 inflates the front airbag 21 through the first gas passage 111. The air enters the first gas passage 111 from the first gas passage inlet 111a and then enters the front airbag cavity 210 from the first gas passage outlet 111b. After inflation, the outer surface of the front airbag 2 is pressed against the deep nasal cavity. If the front airbag 21 is completed after inflation, Stop bleeding, indicating that the bleeding point is at the deep position of the nasal cavity where the front airbag 21 is located. If the bleeding does not stop, continue to use the rear airbag 22 to stop bleeding. The rear airbag 22 is located at the lower part of the front airbag 21. The two ends of the rear airbag 22 are fixed to the outer surface of the support body 1. When not inflated, it is attached to the outer surface of the support body 1. The external air source 6 inflates the rear airbag 22 through the second gas passage 112, enters the second gas passage 112 from the second gas passage inlet 112a, and then enters the rear airbag cavity 220 from the second gas passage outlet 112b. The outer surface of the inflated rear airbag 22 covers the bleeding position at the front end of the nasal cavity. If the rear airbag 22 stops bleeding after inflation, it indicates that the bleeding point is at a shallow position in the nasal cavity where the rear airbag 22 is located. The first gas passage inlet 111a and the second gas passage inlet 112a are provided with a gas blocking component or a one-way valve to prevent gas leakage.

[0082] It should be noted here that the deep position of the nasal cavity and the shallow position of the nasal cavity mentioned in this article are relative, because the supporting body 1 of the device can make the hemostatic airbag 2 penetrate into any position of the nasal cavity, and the front airbag 21 of the hemostatic airbag 2 is located upstream of the rear airbag 22, such as Figure 1 As shown, the specific position of the device in the nasal cavity can be adjusted according to needs. In order to further know the specific position of the hemostatic airbag 2 in the nasal cavity, a size mark 3 is provided on the outer surface of the support body 1. The size mark 3 is a convex circle and a size number set on the outer surface of the support body 1, which is used to display the depth of the device entering the nasal cavity and assist in judging the specific position of the bleeding point.

[0083] refer to Figure 1 , Figure 2 , Figure 5As shown, in order to ensure that the nasal hemostasis device is in conformity with the angle inside the human nasal cavity and is more suitable for the bleeding position of the human nasal cavity to stop bleeding, a steering part 12 is provided on the support body 1 between the front airbag 21 and the rear airbag 22, specifically a section of a corrugated tube 121 provided on the support body 1, located between the front airbag 21 and the rear airbag 22. When the corrugated tube 121 is bent, a part is squeezed and shortened, and the opposite side is stretched and lengthened, so that the support body 1 can be bent, and the front airbag 21 and the rear airbag 22 are bent into an angle suitable for the human nasal cavity, so that the hemostatic airbag 2 is more suitable for the bleeding position of the human nasal cavity, and the hemostatic airbag 2 is more suitable for the bleeding position of the human nasal cavity, and the hemostatic effect is enhanced. The corrugated tube 121 is made of medical grade stainless steel or medical grade plastic. In order to ensure the hemostatic effect of the gap between the front airbag 21 and the rear airbag 22, a connecting bag 23 is arranged therebetween. One end of the connecting bag 23 is fixed on the front airbag 21, and the other end is fixed on the rear airbag 22, covering the steering part 12 as a whole. The cavity formed by the connecting bag 23 is a connecting cavity 230. When the front airbag 21 and the rear airbag 22 are inflated, the connecting bag 23 will expand and fill due to the pulling action of the front airbag 21 and the rear airbag 22, which has a hemostatic effect on the bleeding point and can cover the steering part 12 to prevent it from contacting with blood and causing contamination and damage. When the nasal bleeding site is in the gap between the front airbag 2 and the rear airbag 3, the connecting bag 23 is needed to provide pressure to press the bleeding point to stop bleeding. The third gas passage 113 of the gas passage 11 buried inside the tube wall 13 is used to inflate the connecting bag 23. The air enters the third gas passage 113 from the third gas passage inlet 113a, and then enters the connecting cavity 230 of the connecting bag 23 from the third gas passage outlet 113b. After the connecting bag 23 is filled, it is tightly attached to the inner wall of the human nasal cavity to control bleeding.

[0084] The above-mentioned hemostatic airbag 2 is divided into a front airbag 21, a rear airbag 22 and a connecting airbag 23. Each airbag is controlled by the first gas passage 111, the second gas passage 112 and the third gas passage 113 of the gas passage 11 respectively. The inflation of any airbag can be controlled at will to accurately determine the location of the nasal bleeding point and quickly stop bleeding.

[0085] refer to Figure 3As shown, a pressure relief port 114 is provided on the gas passage 11 of the support body 1. The pressure relief port 114 is located at the lower part of the support body 1 and is connected to the front airbag cavity 210, the rear airbag cavity 220 and the connecting cavity 230 through the first gas passage 111, the second gas passage 112 and the third gas passage 113. The pressure relief port 114 is provided on the first gas passage 111, the second gas passage 112 and the third gas passage 113. A pressure relief valve 71 is sleeved on the outer surface of the support body 1. The pressure relief valve 71 is made of medical rubber. The sealing sleeve of the pressure relief valve 71 is provided outside the pressure relief port 114. When the internal pressure of the front airbag cavity 210, the rear airbag cavity 220 and the connecting cavity 230 is at a safety threshold, the pressure relief port 114 is kept airtight. When the pressure of one of the front airbag cavity 210, the rear airbag cavity 220, and the connecting cavity 230 exceeds the safety pressure relief threshold, the pressure relief valve 71 at the pressure relief port 114 connected to the cavity is opened to relieve the pressure of the cavity. Of course, the front airbag cavity 210, the rear airbag cavity 220, and the connecting cavity 230 can also be relieved at the same time. The safety pressure relief threshold is adjusted according to the patient's condition, and it is recommended that it is not greater than 4Kpa to avoid damage to the nasal cavity caused by excessive compression.

[0086] Continue to refer Figure 1 As shown, a cryogenic liquid bag 72 is further provided inside the front airbag 21 and the rear airbag 22. A cryogenic liquid, such as ice water, cryogenic gel, etc., is filled into the cryogenic liquid bag 72 through a liquid bag pipeline. When the cryogenic liquid bag 72 is filled and expanded, the outer surface of the cryogenic liquid bag 72 is respectively attached to the inner surface of the front airbag 21 and the inner surface of the rear airbag 22, so as to transfer the low temperature to the mucosa in the nasal cavity, thereby assisting the nasal blood vessels to stop bleeding quickly.

[0087] Continue to refer Figure 2 As shown, a pressure monitoring component 74 can be provided inside the front airbag cavity 210, the rear airbag cavity 220, and the connecting cavity 230. The pressure monitoring component 74 is used to monitor the gas pressure inside each cavity. When the safety pressure relief threshold is exceeded, active pressure relief can be taken to avoid damage to the inner wall of the nasal cavity caused by excessive pressure. The outer surfaces of the front airbag 21, the rear airbag 22, and the connecting cavity 23 are provided with a pit 75, and thrombin is provided inside the pit 75. The thrombin is a sterile lyophilized product of thrombin obtained by activating prothrombin.

[0088] refer to Figure 6 , Figure 7As shown, hemostatic gel 73 is provided on the outer surfaces of the front airbag 21, the rear airbag 22, and the connecting bag 23 to enhance the hemostatic effect. The external gas source 6 is a manual airbag 61 or an electric air pump 62, wherein the manual airbag 61 has a compressible airbag cavity 60, and a gas one-way valve 63 is provided at the tail. The manual airbag 61 is pressed to inject external gas into the gas passage 11 of the supporting body 1. A connecting tube 56 is provided at the tail of the supporting body 1, one end of which is connected to the gas passage 11 of the supporting body 1, and the other end is connected to the gas control valve 5. The mark 52 of the gas control valve 5 is located on the lower plate 54, and the pointer 51 is located on the upper plate 53. The lower plate 54 is movably rotatably buckled with the upper plate 53, and is connected to the connecting tube 56 after buckling. When the pointer 51 on the upper plate 53 is rotated and points to a certain passage in the mark 52, the manual airbag 61 is connected to the gas passage, such as: the mark 52 corresponds to There are a first gas passage 111, a second gas passage 112, and a third gas passage 113. When the pointer 51 points to the first gas passage 111 marked with 52, the manual airbag 61 is connected to the first gas passage inlet 111a of the first gas passage 111 through the gas control valve 5. A blocking valve 55 is provided at the first gas passage inlet 111a. When the manual airbag 61 is inflated, the blocking valve 55 automatically blocks the first gas passage inlet 111a to prevent the gas inside the bag from leaking from the first gas passage inlet 111a.

[0089] In addition, the support body 1 can be a solid structure, that is, it does not have an internal hollow nasal ventilation cavity 10, but is provided with a gas passage 11, which is not reflected in the drawings of the specification of this article. It is explained here that the support body 1 with a solid structure does not affect the hemostatic effect of the device and belongs to the protection scope of the present invention.

[0090] The second embodiment of the nasal hemostasis device provided by the present invention is introduced below.

[0091] refer to Figure 8 , Fig. 9 As shown, the second embodiment of the nasal hemostasis device provided by the present invention has basically the same structure as the first embodiment, and the difference between the two is that:

[0092] The steering part 12 is provided on the support body 1 between the front airbag 21 and the rear airbag 22. The steering part 12 is specifically a metal component 122 buried inside the tube wall 13 of the support body 1. The metal component 122 is made of medical-grade stainless steel wire or stainless steel sheet. The diameter of the stainless steel wire is between 0.2-1mm, the thickness of the stainless steel sheet is between 0.2-1mm, and the width is the same as the thickness of the sheet. A rubber film is wrapped around the outside of the metal component 122. The metal component 122 is prefabricated inside the tube wall 13 of the support body 1 to form a steering part 12. By bending the metal component 122, the support body 1 is bent to form an angle suitable for the human nasal cavity. The hemostatic airbag 2 fits the bleeding position of the human nasal cavity better, enhancing the hemostatic effect.

[0093] The third embodiment of the nasal hemostasis device provided by the present invention is introduced below.

[0094] refer to Fig.10 , Fig.11 As shown, the third embodiment of the nasal hemostasis device provided by the present invention has basically the same structure as the first embodiment, and the difference between the two is that:

[0095] The steering part 12 is specifically a metal shaping hose 123, which is made of stainless steel and has a diameter determined according to the diameter of the support body 1. The metal shaping hose 123 is located between the front airbag 21 and the rear airbag 22, and is sleeved on the outside of the support body 1 to form a part of the support body 1. The metal shaping hose 123 is bent to form an angle suitable for the human nasal cavity. The front airbag 21 and the rear airbag 22 are also relatively bent and are conformally located inside the human nasal cavity, which better fits the bleeding position of the human nasal cavity and enhances the hemostatic effect.

Claims

1. A nasal hemostasis device, comprising a supporting body (1) and a hemostatic airbag (2), wherein the supporting body (1) is provided with a gas passage (11) through which gas needs to pass when inflating the hemostatic airbag (2), wherein the gas passage (11) at least comprises a first gas passage (111) and a second gas passage (112), wherein the hemostatic airbag (2) at least comprises a front airbag (21) and a rear airbag (22), wherein the rear airbag (22) is located at the lower part of the front airbag (21), and when not inflated, the hemostatic airbag (2) is attached to the outer surface of the supporting body (1), wherein the first gas passage (111) is used to inflate the front airbag (21) to expand it, and the cavity formed after the expansion is the front airbag cavity (210), and the second gas passage (112) is used to inflate the rear airbag (22) to expand it, and the cavity formed after the expansion is the rear airbag cavity (220), wherein the device is characterized in that: A steering portion (12) is provided on the support body (1) between the front airbag (21) and the rear airbag (22). The steering portion (12) can be bent so that the support body (1) between the front airbag (21) and the rear airbag (22) is bent, and the bending angle is conformable to the human nasal cavity. A connecting bag (23) is provided between the front airbag (21) and the rear airbag (22). One end of the connecting bag (23) is fixed to the front airbag (21), and the other end is fixed to the rear airbag (22), and the entirety covers the steering portion (12). The cavity formed by the connecting bag (23) is a connecting cavity (230). The gas passage (11) further includes a third gas passage (113). The third gas passage (113) is used to inflate the connecting bag (23). It expands, the turning part (12) is a bellows (121), and the bellows (121) is a part of the support body (1); or the turning part (12) is a metal component (122) pre-set inside the tube wall (13) of the support body (1); or the turning part (12) is a metal shaped hose (123), and the metal shaped hose (123) is a part of the support body (1); the gas passage (11) is located inside the support body (1), and the gas passage (11) includes a first gas passage (111) and a second gas passage (112); the hemostatic airbag (2) includes a front airbag (21) and a rear airbag (22), and the front airbag (21) is adjacent to the top of the support body (1).

2. The nasal hemostasis device according to claim 1, characterized in that: The support body (1) is in the shape of an elongated tube, and the hollow inner cavity enclosed by the tube wall (13) is the nasal ventilation cavity (10). A gas passage (11) is provided inside the tube wall (13), and one end of the gas passage (11) is connected to the hemostatic air bag (2), and the other end extends to the end of the support body (1) and is connected to an external gas source (6).

3. The nasal hemostasis device according to claim 1 or 2, characterized in that: The upper end of the bellows (121) is provided with a front air bag (21), and the lower end is provided with a rear air bag (22). When the bellows (121) is bent, a portion is squeezed and shortened, while the opposite side is stretched and lengthened, and the supporting body (1) is bent to form an angle suitable for the human nasal cavity.

4. The nasal hemostasis device according to claim 1 or 2, characterized in that: When the metal component (122) is bent, the supporting body (1) is bent to form an angle suitable for the human nasal cavity.

5. The nasal hemostasis device according to claim 1 or 2, characterized in that: The upper end of the metal shaping hose (123) is provided with a front air bag (21), and the lower end is provided with a rear air bag (22). When the metal shaping hose (123) is bent, the supporting body (1) is bent to form an angle suitable for the human nasal cavity.

6. The nasal hemostasis device according to claim 1, characterized in that: The gas passage (11) of the support body (1) is connected to a gas control valve (5), one end of which is connected to an external gas source (6), and the other end of which is connected to a first gas passage (111) and a second gas passage (112), so as to instruct and control the external gas source (6) to inflate the first gas passage (111) or the second gas passage (112).

7. The nasal hemostasis device according to claim 1, characterized in that: A pressure relief port (114) is provided on the gas passage (11) of the support body (1), and a pressure relief valve (71) is provided on the outer surface of the support body (1). The pressure relief valve (71) seals the pressure relief port (114). When the pressure in the hemostatic airbag (2) exceeds a safe pressure relief threshold, the pressure relief valve (71) releases the seal on the pressure relief port (114) to relieve pressure.

8. The nasal hemostasis device according to claim 1, characterized in that: The front airbag (21) and the rear airbag (22) A cryogenic liquid bag (72) is also provided inside, and cryogenic liquid is filled into the cryogenic liquid bag (72) through a liquid bag pipeline. After the cryogenic liquid bag (72) is filled and expanded, the outer surface of the cryogenic liquid bag (72) is respectively in contact with the inner surface of the front air bag (21) and the inner surface of the rear air bag (22).

9. The nasal hemostasis device according to claim 1, characterized in that: The invention also includes a pressure monitoring component (74) for monitoring the cavity pressure of the front airbag cavity (210) and / or the rear airbag cavity (220).

10. The nasal hemostasis device according to claim 1, characterized in that: The outer surface of the supporting body (1) is provided with a size mark (3), and the size mark (3) indicates the depth of the device entering the nasal cavity, thereby assisting in determining the location of the bleeding point.

Images